MedTech Innovation: Regulatory Hurdles in 2026
MedTech innovators: Avoid 18-month delays. Learn how early regulatory work and dedicated teams reduce FDA compliance issues by…
Vetting AI Health Tools: 5 Steps for 2026
Worried about AI patient safety? Get 5 steps to vet AI health tools by 2026, ensuring clinical efficacy…
AI Health Vendor Due Diligence: 5 Risks in 2026
Is your AI vendor due diligence enough for 2026? Identify 5 critical risks, from HIPAA compliance to algorithmic…
AI Medication Adherence: Unlocking Billions in Value
When patients don’t take their medicine, it creates a massive public health problem and costs the system billions…
Clinical Outcomes: The New Gold Standard for Digital Health AI Investment
Digital health is finally growing up. For years, venture-backed platforms were valued on fuzzy metrics like user engagement…
AI’s Billion-Dollar Impact: Measurable BP Reduction & ROI
Uncontrolled hypertension is a global health crisis, but for investors, it’s simpler: it’s an economic problem that costs…
AI for Hypertension: Which Vendors Prove Adherence?
Medication non-adherence in hypertension isn’t a small problem, it costs healthcare systems billions of dollars, worsens patient outcomes,…
Cardiac AI: Validating Clinical Outcomes for Investor Growth
The AI market for chronic disease is a mess. Everyone claims they can deliver cardiovascular improvements, but when…
AI Health Outcomes: De-Risking Hypertension Investment
The promise of artificial intelligence in healthcare is vast, but for investors navigating the burgeoning market of AI-powered…
AI’s Heartbeat: Driving Adherence, Unlocking Cardiovascular ROI
Investors navigating the burgeoning digital health landscape are increasingly seeking high-growth assets, but the true north for identifying…